ViiV Healthcare, a GSK-majority-owned HIV specialist, has committed to making at least two million doses of its long-acting ...

Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical companies, including Eli Lilly, and pharmacy ...

Orum Therapeutics, specializing in degrader-antibody conjugates, has filed for a $67 million IPO on South Korea's Kosdaq. The ...

AstraZeneca has entered into an exclusive license agreement with China’s CSPC Pharmaceutical to advance the development of an ...

Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including ...

AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...

BeiGene has launched Tevimbra (tislelizumab) in the USA for treating adults with esophageal squamous cell carcinoma (ESCC) ...

South Korea’s ABL Bio Corp (KS: 298380) on Friday revealed that it has entered into a clinical trial collaboration and supply ...

Kezar Life Sciences has paused its Phase IIb PALIZADE trial for zetomipzomib in lupus nephritis after four patient deaths, ...

Orchard Therapeutics has partnered with Turkish drugmaker Er-Kim for the exclusive distribution of its gene therapy, Libmeldy ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) revealed it is discontinuing the Phase II field study (NCT05201794) ...

ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of ...